PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
15-Aug-2024 Encision Reports First Quarter Fiscal Year 2025 Results AccessWire
15-Aug-2024 CoCrystal Pharma to Present at August 20th Virtual Investor Summit Microcap Event AccessWire
15-Aug-2024 ASTCT Applauds FDA Approval of Axatilimab-Csfr for the Treatment of Chronic Graft-Versus-Host Disease (cGVHD) AccessWire
15-Aug-2024 CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product AccessWire
15-Aug-2024 Advanced eClinical Ranked #1 on Forbes Education’s Best CMA Certification Online List AccessWire
15-Aug-2024 Prognos Health Empowers Faster, More Targeted Interventions With New Daily HCP Alerts Offering Newswire
15-Aug-2024 Phastar named in 2024 Environment 100 List Phastar
15-Aug-2024 SFWJ/MedCana Will Eliminate All Convertible Debt by the End of the 3rd Quarter AccessWire
15-Aug-2024 Sagesse Bio Accelerates Development of SGY-101 into clinical development for Targeted Fat Reduction in Aesthetic Medicine and Medical Dermatology AccessWire
15-Aug-2024 Scientific Industries Reports Second Quarter 2024 Results AccessWire
15-Aug-2024 Medical Component Specialists Expands Quick Ship Program AccessWire
15-Aug-2024 DEXIS Launches DEXIS Connect Pro, a New Proactive Service Platform for DEXIS CBCT and Intraoral Sensor Devices, Focused on Increasing Device Uptime AccessWire
15-Aug-2024 First Licensed Adult-Use Cannabis Dispensary in New Rochelle is Woman Owned and Ready to Help Educate the Community AccessWire
15-Aug-2024 OS Therapies Reports Second Quarter 2024 Financial Results AccessWire
15-Aug-2024 CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results AccessWire
15-Aug-2024 Indica Labs Announces Suite of HALO AI Apps to Power Life Sciences Image Analysis Workflows AccessWire
15-Aug-2024 CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update AccessWire
15-Aug-2024 CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study in Patients with Resected Glioblastoma AccessWire
15-Aug-2024 CureVac Names Oncologist and Drug Development Expert Dr. Mehdi Shahidi to Supervisory Board AccessWire
15-Aug-2024 CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update CureVac